{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:40:56Z","timestamp":1790970056334,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study evaluates the impact of medical versus combined medical and surgical glaucoma treatments on patients\u2019 quality of life (QoL). While both approaches reduce intraocular pressure, research shows mixed effects on QoL. Given updated clinical guidelines and the gap in QoL-focused glaucoma management, this study applies validated QoL measures to assess treatment effects and inform patient-centered care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From June to October 2023, 180 patients at Augusta University Eye Care Center completed the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25) and Glaucoma Profile Instrument (GPI) surveys. Chart reviews provided demographic and clinical data, including glaucoma status and treatment. QoL scores were calculated using validated algorithms. Associations between clinical variables and QoL outcomes were analyzed using ANOVA and t-tests in R 4.4.1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 180 patients, 103 had glaucoma or were suspects. 64% of glaucoma patients received medical treatment only, and 34% received combined medical and surgical treatment. VFQ-25 scores differed significantly by race (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0489), severity (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0001), and age (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0459), but not by gender, glaucoma status, or treatment. Severe glaucoma patients had the lowest QoL. Severity strongly impacted GPI scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0092) and multiple VFQ-25 domains. Differences by treatment modality were observed only in the driving subscale (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0378). No significant differences were observed in overall QoL scores between treatment groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>No significant vision-related QoL differences were found between treatment groups. Most patients were medically managed, possibly reflecting limited QoL benefit from surgery. QoL correlated more with disease severity than treatment modality or demographics. These findings highlight a disconnect between current treatment strategies and patient-perceived outcomes, underscoring the need for innovative strategies to improve QoL in glaucoma care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10792-025-03895-7","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T09:07:35Z","timestamp":1766999255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of treatment modality on quality of life in glaucoma patients: findings from a clinical survey study in Augusta, GA"],"prefix":"10.1007","volume":"46","author":[{"given":"Neel","family":"Edupuganti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Chishom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Alevy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"T\u00f6teberg-Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"3895_CR1","unstructured":"Dietze J, Blair K, Zeppieri M, Havens SJ (2024) Glaucoma. StatPearls."},{"issue":"6","key":"3895_CR2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s12325-016-0333-6","volume":"33","author":"L Quaranta","year":"2016","unstructured":"Quaranta L, Riva I, Gerardi C, Oddone F, Floriani I, Konstas AG (2016) Quality of life in glaucoma: a review of the literature. Adv Ther 33(6):959\u2013981. https:\/\/doi.org\/10.1007\/s12325-016-0333-6","journal-title":"Adv Ther"},{"issue":"1","key":"3895_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-022-01979-x","volume":"20","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Zhou W, Song D et al (2022) Vision-related quality of life in patients with glaucoma: the role of illness perceptions. Health Qual Life Outcomes 20(1):78. https:\/\/doi.org\/10.1186\/s12955-022-01979-x","journal-title":"Health Qual Life Outcomes"},{"issue":"10","key":"3895_CR4","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1007\/s00417-023-06050-z","volume":"261","author":"K Latif","year":"2023","unstructured":"Latif K, Nishida T, Moghimi S, Weinreb RN (2023) Quality of life in glaucoma. Graefes Arch Clin Exp Ophthalmol 261(10):3023\u20133030. https:\/\/doi.org\/10.1007\/s00417-023-06050-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"3895_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43203-9","volume":"9","author":"I Riva","year":"2019","unstructured":"Riva I, Legramandi L, Rulli E et al (2019) Vision-related quality of life and symptom perception change over time in newly-diagnosed primary open angle glaucoma patients. Sci Rep 9(1):6735. https:\/\/doi.org\/10.1038\/s41598-019-43203-9","journal-title":"Sci Rep"},{"issue":"48","key":"3895_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008019","volume":"96","author":"Y Wang","year":"2017","unstructured":"Wang Y, Alnwisi S, Ke M (2017) The impact of mild, moderate, and severe visual field loss in glaucoma on patients\u2019 quality of life measured via the Glaucoma Quality of Life-15 Questionnaire: a meta-analysis. Medicine (Baltimore) 96(48):e8019. https:\/\/doi.org\/10.1097\/MD.0000000000008019","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"3895_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5005\/jp-journals-10078-1242","volume":"13","author":"M Dhawan","year":"2019","unstructured":"Dhawan M, Hans T, Sandhu PS, Midha N (2019) Evaluation of vision-related quality of life in patients with glaucoma: a hospital-based study. J Curr Glaucoma Pract 13(1):9\u201315. https:\/\/doi.org\/10.5005\/jp-journals-10078-1242","journal-title":"J Curr Glaucoma Pract"},{"issue":"1","key":"3895_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2011.05.033","volume":"153","author":"SE Skalicky","year":"2012","unstructured":"Skalicky SE, Goldberg I, McCluskey P (2012) Ocular surface disease and quality of life in patients with glaucoma. Am J Ophthalmol 153(1):1. https:\/\/doi.org\/10.1016\/j.ajo.2011.05.033","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"3895_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/jnu.12540","volume":"52","author":"C Cheng","year":"2020","unstructured":"Cheng C, Yang CY, Inder K, Chan SW (2020) Illness perceptions, coping strategies, and quality of life in people with multiple chronic conditions. J Nurs Scholarsh 52(2):145\u2013154. https:\/\/doi.org\/10.1111\/jnu.12540","journal-title":"J Nurs Scholarsh"},{"issue":"6","key":"3895_CR10","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.4103\/ijo.IJO_2239_21","volume":"70","author":"N Mohan","year":"2022","unstructured":"Mohan N, Chakrabarti A, Nazm N, Mehta R, Edward DP (2022) Newer advances in medical management of glaucoma. Indian J Ophthalmol 70(6):1920\u20131930. https:\/\/doi.org\/10.4103\/ijo.IJO_2239_21","journal-title":"Indian J Ophthalmol"},{"issue":"7","key":"3895_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ophtha.2024.01.007","volume":"131","author":"AJ King","year":"2024","unstructured":"King AJ, Hudson J, Azuara-Blanco A et al (2024) Evaluating primary treatment for people with advanced glaucoma: five-year results of the Treatment of Advanced Glaucoma Study. Ophthalmology 131(7):759\u2013770. https:\/\/doi.org\/10.1016\/j.ophtha.2024.01.007","journal-title":"Ophthalmology"},{"issue":"11","key":"3895_CR12","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/S0161-6420(01)00907-1","volume":"108","author":"D Minckler","year":"2001","unstructured":"Minckler D (2001) Medical versus surgical therapy in early glaucoma. Ophthalmology 108(11):1939\u20131940. https:\/\/doi.org\/10.1016\/S0161-6420(01)00907-1","journal-title":"Ophthalmology"},{"issue":"1","key":"3895_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/meajo.meajo_146_22","volume":"29","author":"FC Oduneye","year":"2022","unstructured":"Oduneye FC, Musa KO, Agboola SA, Idowu OO, Onakoya AO (2022) The quality of life of medically versus surgically treated primary open-angle glaucoma patients at a Nigerian Hospital. Middle East Afr J Ophthalmol 29(1):7\u201314. https:\/\/doi.org\/10.4103\/meajo.meajo_146_22","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"11","key":"3895_CR14","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/s0161-6420(01)00874-0","volume":"108","author":"NK Janz","year":"2001","unstructured":"Janz NK, Wren PA, Lichter PR et al (2001) The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology 108(11):1954\u20131965. https:\/\/doi.org\/10.1016\/s0161-6420(01)00874-0","journal-title":"Ophthalmology"},{"issue":"7","key":"3895_CR15","first-page":"2660","volume":"61","author":"I Riva","year":"2020","unstructured":"Riva I, Micheletti E, Legramandi L, Bruttini C, Arpa C, Quaranta L (2020) The effect of glaucoma treatments on quality of life. Invest Ophthalmol Vis Sci 61(7):2660\u20132660","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"3895_CR16","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1097\/IJG.0000000000000554","volume":"26","author":"M Matsuura","year":"2017","unstructured":"Matsuura M, Hirasawa K, Hirasawa H et al (2017) Developing an item bank to measure quality of life in individuals with glaucoma, and the results of the interview with patients: the effect of visual function, visual field progression rate, medical, and surgical treatments on quality of life. J Glaucoma 26(2):e64\u2013e73. https:\/\/doi.org\/10.1097\/IJG.0000000000000554","journal-title":"J Glaucoma"},{"issue":"5","key":"3895_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/IJG.0b013e31824ceb8b","volume":"22","author":"RA Guedes","year":"2013","unstructured":"Guedes RA, Guedes VM, Freitas SM, Chaoubah A (2013) Quality of life of medically versus surgically treated glaucoma patients. J Glaucoma 22(5):369\u2013373. https:\/\/doi.org\/10.1097\/IJG.0b013e31824ceb8b","journal-title":"J Glaucoma"},{"issue":"5","key":"3895_CR18","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/s0161-6420(00)00624-2","volume":"108","author":"NK Janz","year":"2001","unstructured":"Janz NK, Wren PA, Lichter PR, Musch DC, Gillespie BW, Guire KE (2001) Quality of life in newly diagnosed glaucoma patients\u202f: The Collaborative Initial Glaucoma Treatment Study. Ophthalmology 108(5):887\u2013898. https:\/\/doi.org\/10.1016\/s0161-6420(00)00624-2","journal-title":"Ophthalmology"},{"issue":"2","key":"3895_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00055735-200304000-00006","volume":"14","author":"DR Anderson","year":"2003","unstructured":"Anderson DR (2003) Collaborative normal tension glaucoma study. Curr Opin Ophthalmol 14(2):86\u201390. https:\/\/doi.org\/10.1097\/00055735-200304000-00006","journal-title":"Curr Opin Ophthalmol"},{"key":"3895_CR20","doi-asserted-by":"publisher","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, et al (2022) The Ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 120(6):701\u201313; discussion 829\u201330. https:\/\/doi.org\/10.1001\/archopht.120.6.701","DOI":"10.1001\/archopht.120.6.701"},{"issue":"3","key":"3895_CR21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ophtha.2004.11.030","volume":"112","author":"S Miglior","year":"2005","unstructured":"Miglior S, Zeyen T, Pfeiffer N et al (2005) Results of the European glaucoma prevention study. Ophthalmology 112(3):366\u2013375. https:\/\/doi.org\/10.1016\/j.ophtha.2004.11.030","journal-title":"Ophthalmology"},{"issue":"11","key":"3895_CR22","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/s0161-6420(99)90497-9","volume":"106","author":"MC Leske","year":"1999","unstructured":"Leske MC, Heijl A, Hyman L, Bengtsson B (1999) Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 106(11):2144\u20132153. https:\/\/doi.org\/10.1016\/s0161-6420(99)90497-9","journal-title":"Ophthalmology"},{"issue":"1","key":"3895_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ophtha.2012.07.028","volume":"120","author":"DF Garway-Heath","year":"2013","unstructured":"Garway-Heath DF, Lascaratos G, Bunce C et al (2013) The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, placebo-controlled clinical trial: design and methodology. Ophthalmology 120(1):68\u201376. https:\/\/doi.org\/10.1016\/j.ophtha.2012.07.028","journal-title":"Ophthalmology"},{"key":"3895_CR24","doi-asserted-by":"publisher","unstructured":"The Advanced Glaucoma Intervention Study (AGIS) (Oct 2000) 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators. Am J Ophthalmol. 130(4):429\u201340. https:\/\/doi.org\/10.1016\/s0002-9394(00)00538-9","DOI":"10.1016\/s0002-9394(00)00538-9"},{"issue":"4","key":"3895_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/s0161-6420(99)90147-1","volume":"106","author":"DC Musch","year":"1999","unstructured":"Musch DC, Lichter PR, Guire KE, Standardi CL (1999) The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology 106(4):653\u2013662. https:\/\/doi.org\/10.1016\/s0161-6420(99)90147-1","journal-title":"Ophthalmology"},{"key":"3895_CR26","doi-asserted-by":"publisher","unstructured":"European Glaucoma Society Terminology and Guidelines for Glaucoma (Jun 2021) 5th Edition. Br J Ophthalmol. 105(Suppl 1):1\u2013169. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-egsguidelines","DOI":"10.1136\/bjophthalmol-2021-egsguidelines"},{"issue":"9","key":"3895_CR27","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.ophtha.2012.02.050","volume":"119","author":"SL Mansberger","year":"2012","unstructured":"Mansberger SL, Gordon MO, Jampel H et al (2012) Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study. Ophthalmology 119(9):1826\u20131831. https:\/\/doi.org\/10.1016\/j.ophtha.2012.02.050","journal-title":"Ophthalmology"},{"issue":"7","key":"3895_CR28","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD (2001) Development of the 25-item National eye institute visual function questionnaire. Arch Ophthalmol 119(7):1050\u20131058. https:\/\/doi.org\/10.1001\/archopht.119.7.1050","journal-title":"Arch Ophthalmol"},{"key":"3895_CR29","doi-asserted-by":"crossref","unstructured":"Mangione CM (2000) The National Eye Institute 25-Item Visual Function Questionnaire (VFQ-25).","DOI":"10.1037\/t08622-000"},{"issue":"8","key":"3895_CR30","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/OPX.0b013e3181339f30","volume":"84","author":"JM Burr","year":"2007","unstructured":"Burr JM, Kilonzo M, Vale L, Ryan M (2007) Developing a preference-based glaucoma utility index using a discrete choice experiment. Optom Vis Sci 84(8):797\u2013808. https:\/\/doi.org\/10.1097\/OPX.0b013e3181339f30","journal-title":"Optom Vis Sci"},{"key":"3895_CR31","unstructured":"R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2024. https:\/\/www.R-project.org\/"},{"issue":"3","key":"3895_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/09286586.2020.1863992","volume":"28","author":"N Khachatryan","year":"2021","unstructured":"Khachatryan N, Pistilli M, Maguire MG et al (2021) A review of studies of the association of vision-related quality of life with measures of visual function and structure in patients with glaucoma in the United States. Ophthalmic Epidemiol 28(3):265\u2013276. https:\/\/doi.org\/10.1080\/09286586.2020.1863992","journal-title":"Ophthalmic Epidemiol"},{"issue":"4","key":"3895_CR33","first-page":"366","volume":"54","author":"N Jaint","year":"2010","unstructured":"Jaint N, Verma P, Mittal S, Mittal S, Singh AK, Munjal S (2010) Gender based alteration in color perception. Indian J Physiol Pharmacol 54(4):366\u2013370","journal-title":"Indian J Physiol Pharmacol"},{"key":"3895_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ajo.2022.05.023","volume":"242","author":"OA Halawa","year":"2022","unstructured":"Halawa OA, Jin Q, Pasquale LR et al (2022) Race and ethnicity differences in disease severity and visual field progression among glaucoma patients. Am J Ophthalmol 242:69\u201376. https:\/\/doi.org\/10.1016\/j.ajo.2022.05.023","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"3895_CR35","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.4103\/IJO.IJO_56_23","volume":"71","author":"A Tripathi","year":"2023","unstructured":"Tripathi A, Agarwal R, Kharya P, Dwivedi P, Khan I (2023) A comparative study of vision-related quality of life (VRQoL) among glaucoma and nonglaucoma patients at a tertiary care center of North India. Indian J Ophthalmol 71(8):3010\u20133015. https:\/\/doi.org\/10.4103\/IJO.IJO_56_23","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"3895_CR36","doi-asserted-by":"publisher","first-page":"552","DOI":"10.4103\/ijo.IJO_1687_21","volume":"70","author":"S Nayyar","year":"2022","unstructured":"Nayyar S, Kumar S, Rehman O, Ichhpujani P, Singla E (2022) Impact of moderate and severe primary open-angle glaucoma on quality of life due to activity limitation. Indian J Ophthalmol 70(2):552\u2013557. https:\/\/doi.org\/10.4103\/ijo.IJO_1687_21","journal-title":"Indian J Ophthalmol"},{"issue":"10","key":"3895_CR37","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1038\/s41433-022-02303-z","volume":"37","author":"AD Deemer","year":"2023","unstructured":"Deemer AD, Goldstein JE, Ramulu PY (2023) Approaching rehabilitation in patients with advanced glaucoma. Eye Lond 37(10):1993\u20132006. https:\/\/doi.org\/10.1038\/s41433-022-02303-z","journal-title":"Eye Lond"},{"issue":"12","key":"3895_CR38","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1038\/eye.2010.133","volume":"24","author":"A van Gestel","year":"2010","unstructured":"van Gestel A, Webers CA, Beckers HJ et al (2010) The relationship between visual field loss in glaucoma and health-related quality-of-life. Eye (Lond) 24(12):1759\u20131769. https:\/\/doi.org\/10.1038\/eye.2010.133","journal-title":"Eye (Lond)"},{"issue":"1","key":"3895_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ogla.2021.04.011","volume":"5","author":"BC Stagg","year":"2022","unstructured":"Stagg BC, Granger A, Guetterman TC, Hess R, Lee PP (2022) The burden of caring for and treating glaucoma: the patient perspective. Ophthalmol Glaucoma 5(1):32\u201339. https:\/\/doi.org\/10.1016\/j.ogla.2021.04.011","journal-title":"Ophthalmol Glaucoma"},{"key":"3895_CR40","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ajo.2021.03.007","volume":"229","author":"TW Samuelson","year":"2021","unstructured":"Samuelson TW, Singh IP, Williamson BK et al (2021) Quality of life in primary open-angle glaucoma and cataract: an analysis of VFQ-25 and OSDI from the iStent inject(R) pivotal trial. Am J Ophthalmol 229:220\u2013229. https:\/\/doi.org\/10.1016\/j.ajo.2021.03.007","journal-title":"Am J Ophthalmol"},{"key":"3895_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ajo.2022.12.018","volume":"248","author":"T Nishida","year":"2023","unstructured":"Nishida T, Moghimi S, Yamane MLM et al (2023) Vision-related quality of life among healthy, preperimetric glaucoma, and perimetric glaucoma patients. Am J Ophthalmol 248:127\u2013136. https:\/\/doi.org\/10.1016\/j.ajo.2022.12.018","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"3895_CR42","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/aos.16697","volume":"102","author":"MM von Arenstorff","year":"2024","unstructured":"von Arenstorff MM, Ahmadzadeh A, Schmidt BS, Kessel L, Bach-Holm D (2024) Vision-related quality of life in patients with glaucoma before and after trabeculectomy. Acta Ophthalmol 102(7):779\u2013789. https:\/\/doi.org\/10.1111\/aos.16697","journal-title":"Acta Ophthalmol"},{"issue":"sup1","key":"3895_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/10810730.2023.2187484","volume":"28","author":"LA Cafferty","year":"2023","unstructured":"Cafferty LA, Williamson LD, Anderson LN et al (2023) How attributes of place threaten community trust in the American South: opportunities for improving pandemic-related communication. J Health Commun 28(sup1):67\u201375. https:\/\/doi.org\/10.1080\/10810730.2023.2187484","journal-title":"J Health Commun"},{"issue":"3","key":"3895_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac050","volume":"9","author":"CA Hamilton","year":"2022","unstructured":"Hamilton CA, Ayyala D, Walsh D et al (2022) Small towns, big cities: rural and urban disparities among hospitalized patients with COVID-19 in the Central Savannah River Area. Open Forum Infect Dis 9(3):ofac050. https:\/\/doi.org\/10.1093\/ofid\/ofac050","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"3895_CR45","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1504\/IJBHR.2011.043414","volume":"2","author":"R Rosenman","year":"2011","unstructured":"Rosenman R, Tennekoon V, Hill LG (2011) Measuring bias in self-reported data. Int J Behav Healthcare Res 2(4):320\u2013332. https:\/\/doi.org\/10.1504\/IJBHR.2011.043414","journal-title":"Int J Behav Healthcare Res"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03895-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03895-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03895-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T09:07:36Z","timestamp":1766999256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03895-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3895"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03895-7","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"19 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients signed informed consent regarding publishing their data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Approval was obtained from the ethics committee of Augusta University. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"55"}}